Sun, Dec 21, 2014, 8:32 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

CEL-SCI Corporation Message Board

  • fosco.sinibaldi fosco.sinibaldi Feb 26, 2013 5:28 AM Flag

    "All efforts are being made to enroll all 880 patients as quickly as possible"

    Geert, I don't want to be sounding negative, but as long as :

    - You will produce news which in fact are not news
    - You will show upgrades from unknown brokers, you wonder whether they are the gold dealer around the corner
    - You will keep running a "state of the art facility" which in theory should have produced in the past years enough Multikine to feed the market for the phase III, phase IV and above
    - You'll keep paying a huge salary to a retiree in Switzerland from which we didn't have any health report for years
    - You'll keep paying yourself twice the salary of my friends who have a much better MBA than you (Wharton, Harvard, Columbia) and state that "you could earn much more out of Cel SCI and you sacrificed yourself"
    - You'll keep showing a ratio of 1 dollar spent on phase III for 5 dollars spent and a never changing $ 25M funds figure for phase III completion
    - You will carry on concealing the most basic recruitment indicators

    ... then it will be hard to convince the street that "all efforts are being put on patients recruitment"

    well JMHO as usual

    Fosco

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • i am sure MARGARET HAMBURG and the FDA will give you the enrollment numbers. THEY are MONITORING and observing MULTIKINE 24 hours a day , 7 days a week. GEERT IS DOING EVERYTHING BY THE BOOK. GEERT IS BUSY ALL DAY LONG RUNNING 46 CENTERS ON 3 CONTINENTS. FLYING TO RUSSIA, THEN TO INDIA THEN TO ISREAL,BACK TO MISSISSIPPI. I THINK GEERT SHOULD GET A RAISE.

      Sentiment: Strong Buy

    • name me any phase 3 trial company that released enrollment numbers. there are none. THE FDA will halt the trial if geert opens his mouth about enrollment. the FDA is watching every move GEERT makes. can't you people wait just 2 more years. what is so bad about buying a cheap stock.

      Sentiment: Strong Buy

      • 3 Replies to roveroo
      • "THE FDA will halt the trial if geert opens his mouth about enrollment."
        LOL
        Are you fool?
        All company gives those numbers !

      • Your point matches a lot of us serious investors, like myself, who are tired of hearing bashers and downers who think it is all a big scam. Cel-Sci got in trouble and paid out for posting too much information on their website in the past. They posted before and after pictures of the tumor and they got nailed by the FDA with a warning letter to remove them immediately and that they cannot provide that level of detail. Ever since, they have been walking a tight rope to not make the same mistakes again. Thank you for the very good post...this is a good long term gamble.

        Also, the facts are, they built a $25 million facility for manufacturing in Baltimore. They shown impressive progress in Phase 2 trials. They received IDMC safety approval for progress thus far and biggest of all they have Teva and Orient - two major companies paying for these trials. If there wasn't something seriously potentially successful here, you wouldn't get the money out of Teva and Orient - they wouldn't waste their time. So, this is NOT a scam...there's a reason the big guys are involved and that is to make money.

        Sentiment: Strong Buy

      • You're a typical CVM shhareholder: dishonest and a fool, too!

        From just yesterday: "REDWOOD CITY, Calif., Feb. 27, 2013 /PRNewswire/ -- Cardica, Inc. (Nasdaq:
        CRDC) today announced that 109 patients have been enrolled in the company's
        European clinical trial designed to evaluate the safety of its MicroCutter
        XCHANGE 30 cutting/stapling device in a variety of surgical procedures. Cardica
        plans to complete enrollment of 160 patients for the European clinical trial in
        the second calendar quarter of 2013. "

        The fact is that all legitimate companies issue updates on how their key clinical trials are progressing. The FDA doesn't forbid that, just statements on the supposed results of a trial while it's in progress.

        Con man Geert refuses to relate any information on enrollment only because it;s dreadful. On the other hand, huckster Geert hints that Multikine is producing good results, something expressly forbidden by FDA (and idiotic since the only real result that matters is 3 year survival and the trial is only a little more than 2 years old now), whenever he needs to grease the skids for another of his sleazy pump and dump financings.

        CVM is one of the slimiest enterprises you'll ever see. That's why it attracts only fools such as you and sleazy jerks such as riverpap.

    • Fosco....I just wish they would give us ONE update with some meaning to it...I know I am in this till the end but there are things they CAN say and they CHOOSE to leave the shareholders out of the loop. I dont believe they know the status of the trial participants but they do know the numbers dosed. From what I have read, they can tell that

 
CVM
0.65+0.0657(+11.24%)Dec 19 4:03 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.